919 results on '"Cancer -- Care and treatment -- Methods"'
Search Results
2. 'Method For Treating Cancer With Acylfulvene And Radiation' in Patent Application Approval Process (USPTO 20240299316)
3. Patent Issued for Methods for treating cancer (USPTO 12084434)
4. Patent Application Titled 'Methods And Materials For Treating Cancer' Published Online (USPTO 20240302367)
5. 'Compositions And Methods For Treating Cancer' in Patent Application Approval Process (USPTO 20240299354)
6. Patent Issued for Blood processing apparatus and method for destroying cancer metastasis in vivo (USPTO 12070541)
7. 'Diagnostic Methods And Compositions For Treatment Of Cancer' in Patent Application Approval Process (USPTO 20240245674)
8. Patent Issued for Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and a PARP inhibitor (USPTO 12036222)
9. Patent Issued for Immunogenic composition for the treatment of cancer and methods of preparing the same (USPTO 12036188)
10. Patent Application Titled 'Compositions And Methods For The Treatment And Prevention Of Cancer' Published Online (USPTO 20240239786)
11. 'Crtam Antibodies And Methods Of Treating Cancer' in Patent Application Approval Process (USPTO 20240228649)
12. Patent Issued for Methods and compositions for identifying neoantigens for use in treating cancer (USPTO 12018252)
13. Patent Application Titled 'Methods Of Treating Cancer With Nonfucosylated Anti-Cd70 Antibodies' Published Online (USPTO 20240166757)
14. 'Methods Of Treating Cancer With A Combination Of A Nonfucosylated Anti-Cd70 Antibody And A Cd47 Antagonist' in Patent Application Approval Process (USPTO 20240165229)
15. Patent Application Titled 'Methods and Compositions for Treating Cancers by Inhibiting Estrogen Signaling in Myeloid-Derived Suppressor Cells' Published Online (USPTO 20240165225)
16. Patent Application Titled 'Compositions And Methods For The Treatment Of Cancer' Published Online (USPTO 20240165135)
17. Patent Application Titled 'Compositions And Methods For Treating Cancer' Published Online (USPTO 20240156813)
18. Patent Issued for Compositions and methods for treating cancer using RHOA dominant negative forms (USPTO 11957739)
19. 'Compositions And Methods For Treating Cancer' in Patent Application Approval Process (USPTO 20240109845)
20. Patent Application Titled 'Methods For Treating Cancer' Published Online (USPTO 20240099996)
21. Patent Issued for Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate (USPTO 11932701)
22. Cancer fatigue: Why it occurs and how to cope
23. Patent Issued for Methods for treating cancer (USPTO 11911367)
24. 'Compounds And Methods Of Treating Cancers' in Patent Application Approval Process (USPTO 20240050428)
25. 'Methods And Compositions For Treating Cd44+ Cancers' in Patent Application Approval Process (USPTO 20240050515)
26. Patent Issued for Methods and compositions for treating cancer (USPTO 11890286)
27. Patent Issued for Method of treating cancer with composition comprising IL-15-based molecules and BCG (USPTO 11890323)
28. Hemogenyx announces Chimeric Bait Receptor, a major breakthrough in the method of brain delivery for combating brain cancers
29. Patent Issued for Isolated peptide, anti-cancer medicinal composition including the same and method of specifically reducing or inhibiting activities of cancer cells using the same (USPTO 11866516)
30. Patent Issued for Methods for treating cancer (USPTO 11857518)
31. Patent Application Titled 'Method of Treating Cancer Using FABP5 Inhibitors' Published Online (USPTO 20230414605)
32. Patent Application Titled 'Immunohistochemistry (Ihc) Protocols And Methods For Diagnosing And Treating Cancer' Published Online (USPTO 20230417752)
33. 'Methods Of Treating Cancer Using Multi-Specific Binding Proteins That Bind Nkg2d, Cd16, And Her2' in Patent Application Approval Process (USPTO 20230416402)
34. Patent Application Titled 'Methods For Determining And Achieving Therapeutically Effective Doses Of Anti-Cd47 Agents In Treatment Of Cancer' Published Online (USPTO 20230406923)
35. Researchers Submit Patent Application, 'Immune Cells With Reduced Androgen Receptor (Ar) Level, And Methods Of Their Use To Enhance Anti-Cancer Therapy', for Approval (USPTO 20240400991)
36. Patent Issued for Kinase inhibitors exhibiting anti-cancer activity and their method of use (USPTO 12157742)
37. Patent Application Titled 'Methods For Treating Cancer' Published Online (USPTO 20240400543)
38. Patent Application Titled 'Compounds And Methods For Treating Cancers That Are Mgmt Deficient Regardless Of Mmr Status' Published Online (USPTO 20240400572)
39. Patent Application Titled 'Claudin 4 And Claudin 9 Antibodies And Methods Of Treating Cancer' Published Online (USPTO 20240400674)
40. Patent Application Titled 'Anti-Nme Antibody And Method Of Treating Cancer Or Cancer Metastasis' Published Online (USPTO 20240392038)
41. Patent Application Titled 'Systems And Methods For Treating Cancer And/Or Augmenting Organ Function' Published Online (USPTO 20240389937)
42. Patent Application Titled 'Methods Of Treating Cancers Associated With Immunosuppressive B Cells' Published Online (USPTO 20240392000)
43. Patent Application Titled 'Methods Of Amplifying Tumor-Reactive Immune Populations Using Organoids' Published Online (USPTO 20240390421)
44. Researchers Submit Patent Application, 'Methods And Composition Using Patient-Derived Autologous Neoantigens For Treating Cancer', for Approval (USPTO 20240382591)
45. Patent Application Titled 'Compositions And Methods For Treating Cancer' Published Online (USPTO 20240374590)
46. Researchers Submit Patent Application, 'Methods And Compositions For Treatment Of Kras Mutant Cancer', for Approval (USPTO 20240374597)
47. Researchers Submit Patent Application, 'Method For Providing Tumour-Specific T Cells', for Approval (USPTO 20240376543)
48. Patent Application Titled 'Oncologic Variations Associated With Cancer And Methods Of Treatment' Published Online (USPTO 20240376547)
49. Patent Issued for Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer (USPTO 12134620)
50. Researchers Submit Patent Application, 'Formulated and/or Co-Formulated Liposome Compositions Containing PD-1 Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof', for Approval (USPTO 20240366772)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.